by The global short-read sequencing market size accounted for US$ 6.3 Bn in 2022 and is projected to reach around USD 36 Bn by 2032, growing at a CAGR of 19.04% from 2023 to 2032.
Report Summary
The global short-read sequencing market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the short-read sequencing market across the globe.
A comprehensive estimate on the short-read sequencing market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of short-read sequencing during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2887
Short-read Sequencing Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 7.5 Billion |
| Market Size by 2032 | USD 36 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 19.4% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Technology, By Workflow, By Product, By Application, and By End User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized short-read sequencing market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Diabetes Drug Market Size To Cross USD 118 Bn By 2032
Short-read Sequencing Market Players
The report includes the profiles of key short-read sequencing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Major companies operating in this area
- BGI
- Agilent Technologies
- Thermo Fisher Scientific, Inc.
- ProPhase Labs, Inc. (Nebula Genomics)
- Illumina, Inc.
- Psomagen
- QIAGEN
- Azenta US, Inc. (GENEWIZ)
- PerkinElmer, Inc.
- Pacific Biosciences of California, Inc.
- Cytiva
- Fasteris SA
- Genewiz
- GenScript
Market Segmentation
By Technology
- Next-Generation Sequencing
- Sanger Sequencing
By Workflow
- Pre-Sequencing
- Sequencing
- Data Analysis
By Product
- Instruments
- Consumables
- Services
By Application
- Clinical Investigation
- Oncology
- Reproductive Health
- Consumer Genomics
- Agri genomics and Forensics
- HLA Typing/ Immune System Monitoring
By End User
- Academic Research
- Hospital and Clinics
- Clinical Research
- Pharmaceutical and Biotechnology Companies
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Short-read Sequencing Market
5.1. COVID-19 Landscape: Short-read Sequencing Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Short-read Sequencing Market, By Technology
8.1. Short-read Sequencing Market, by Technology, 2023-2032
8.1.1. Next-Generation Sequencing
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Sanger Sequencing
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Short-read Sequencing Market, By Workflow
9.1. Short-read Sequencing Market, by Workflow, 2023-2032
9.1.1. Pre-Sequencing
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Sequencing
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Data Analysis
9.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Short-read Sequencing Market, By Product
10.1. Short-read Sequencing Market, by Product, 2023-2032
10.1.1. Instruments
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Consumables
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Services
10.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Short-read Sequencing Market, By Application
11.1. Short-read Sequencing Market, by Application, 2023-2032
11.1.1. Clinical Investigation
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Oncology
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Reproductive Health
11.1.3.1. Market Revenue and Forecast (2020-2032)
11.1.4. Consumer Genomics
11.1.4.1. Market Revenue and Forecast (2020-2032)
11.1.5. Agri genomics and Forensics
11.1.5.1. Market Revenue and Forecast (2020-2032)
11.1.6. HLA Typing/ Immune System Monitoring
11.1.6.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Short-read Sequencing Market, By End User
12.1. Short-read Sequencing Market, by End User, 2023-2032
12.1.1. Academic Research
12.1.1.1. Market Revenue and Forecast (2020-2032)
12.1.2. Hospital and Clinics
12.1.2.1. Market Revenue and Forecast (2020-2032)
12.1.3. Clinical Research
12.1.3.1. Market Revenue and Forecast (2020-2032)
12.1.4. Pharmaceutical and Biotechnology Companies
12.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 13. Global Short-read Sequencing Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Technology (2020-2032)
13.1.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.1.3. Market Revenue and Forecast, by Product (2020-2032)
13.1.4. Market Revenue and Forecast, by Application (2020-2032)
13.1.5. Market Revenue and Forecast, by End User (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Technology (2020-2032)
13.1.6.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.1.6.3. Market Revenue and Forecast, by Product (2020-2032)
13.1.6.4. Market Revenue and Forecast, by Application (2020-2032)
13.1.6.5. Market Revenue and Forecast, by End User (2020-2032)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Technology (2020-2032)
13.1.7.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.1.7.3. Market Revenue and Forecast, by Product (2020-2032)
13.1.7.4. Market Revenue and Forecast, by Application (2020-2032)
13.1.7.5. Market Revenue and Forecast, by End User (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Technology (2020-2032)
13.2.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.2.3. Market Revenue and Forecast, by Product (2020-2032)
13.2.4. Market Revenue and Forecast, by Application (2020-2032)
13.2.5. Market Revenue and Forecast, by End User (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Technology (2020-2032)
13.2.6.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.2.6.3. Market Revenue and Forecast, by Product (2020-2032)
13.2.7. Market Revenue and Forecast, by Application (2020-2032)
13.2.8. Market Revenue and Forecast, by End User (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Technology (2020-2032)
13.2.9.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.2.9.3. Market Revenue and Forecast, by Product (2020-2032)
13.2.10. Market Revenue and Forecast, by Application (2020-2032)
13.2.11. Market Revenue and Forecast, by End User (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Technology (2020-2032)
13.2.12.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.2.12.3. Market Revenue and Forecast, by Product (2020-2032)
13.2.12.4. Market Revenue and Forecast, by Application (2020-2032)
13.2.13. Market Revenue and Forecast, by End User (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Technology (2020-2032)
13.2.14.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.2.14.3. Market Revenue and Forecast, by Product (2020-2032)
13.2.14.4. Market Revenue and Forecast, by Application (2020-2032)
13.2.15. Market Revenue and Forecast, by End User (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Technology (2020-2032)
13.3.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.3.3. Market Revenue and Forecast, by Product (2020-2032)
13.3.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.5. Market Revenue and Forecast, by End User (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Technology (2020-2032)
13.3.6.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.3.6.3. Market Revenue and Forecast, by Product (2020-2032)
13.3.6.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.7. Market Revenue and Forecast, by End User (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Technology (2020-2032)
13.3.8.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.3.8.3. Market Revenue and Forecast, by Product (2020-2032)
13.3.8.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.9. Market Revenue and Forecast, by End User (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Technology (2020-2032)
13.3.10.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.3.10.3. Market Revenue and Forecast, by Product (2020-2032)
13.3.10.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.10.5. Market Revenue and Forecast, by End User (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Technology (2020-2032)
13.3.11.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.3.11.3. Market Revenue and Forecast, by Product (2020-2032)
13.3.11.4. Market Revenue and Forecast, by Application (2020-2032)
13.3.11.5. Market Revenue and Forecast, by End User (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Technology (2020-2032)
13.4.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.4.3. Market Revenue and Forecast, by Product (2020-2032)
13.4.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.5. Market Revenue and Forecast, by End User (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Technology (2020-2032)
13.4.6.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.4.6.3. Market Revenue and Forecast, by Product (2020-2032)
13.4.6.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.7. Market Revenue and Forecast, by End User (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Technology (2020-2032)
13.4.8.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.4.8.3. Market Revenue and Forecast, by Product (2020-2032)
13.4.8.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.9. Market Revenue and Forecast, by End User (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Technology (2020-2032)
13.4.10.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.4.10.3. Market Revenue and Forecast, by Product (2020-2032)
13.4.10.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.10.5. Market Revenue and Forecast, by End User (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Technology (2020-2032)
13.4.11.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.4.11.3. Market Revenue and Forecast, by Product (2020-2032)
13.4.11.4. Market Revenue and Forecast, by Application (2020-2032)
13.4.11.5. Market Revenue and Forecast, by End User (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Technology (2020-2032)
13.5.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.5.3. Market Revenue and Forecast, by Product (2020-2032)
13.5.4. Market Revenue and Forecast, by Application (2020-2032)
13.5.5. Market Revenue and Forecast, by End User (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Technology (2020-2032)
13.5.6.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.5.6.3. Market Revenue and Forecast, by Product (2020-2032)
13.5.6.4. Market Revenue and Forecast, by Application (2020-2032)
13.5.7. Market Revenue and Forecast, by End User (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Technology (2020-2032)
13.5.8.2. Market Revenue and Forecast, by Workflow (2020-2032)
13.5.8.3. Market Revenue and Forecast, by Product (2020-2032)
13.5.8.4. Market Revenue and Forecast, by Application (2020-2032)
13.5.8.5. Market Revenue and Forecast, by End User (2020-2032)
Chapter 14. Company Profiles
14.1. BGI
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Agilent Technologies
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Thermo Fisher Scientific, Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. ProPhase Labs, Inc. (Nebula Genomics)
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Illumina, Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Psomagen
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. QIAGEN
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Azenta US, Inc. (GENEWIZ)
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. PerkinElmer, Inc.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Pacific Biosciences of California, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
